Research on Mental Health in the Aftermath of Environmental Disasters Soaring
New research led by the Yale School of Public Health finds that the number of studies on how environmental disasters affect mental health has increased dramatically and that they consistently find strong associations with survivor’s mental health outcomes.
Suicide is Preventable. So, How Can We Help Our Teens?
Suicide is preventable, but rates of suicide are increasing worldwide, and it is now the second leading cause of death in adolescents and young adults (unintentional motor vehicle accidents are first). Going to the emergency room may be the smartest thing these teenagers can do.
MOMS Partnership® Featured in NASEM Report as 'Promising Model'
The MOMS Partnership® is identified as a "Promising Model" in a report by the National Academies of Sciences, Engineering, and Medicine titled, "Vibrant and Health Kids: Aligning Science, Practice, and Policy to Advance Health Equity."
Better Science, Better Lives: Women's Health Research at Yale is Working for You
Across the country, it’s becoming clearer every day: We must study the health of women. We must study the influence of sex-and-gender differences on health. And it’s time for all aspects of medical research and practice to embrace this change.
WHRY funds studies on pain relief, cannabis, and genetic origins of sex differences in disease
WHRY announces funding for first-of-their-kind studies on pain relief, cannabis, and the genetic basis of sex differences across a broad range of ailments, including Alzheimer’s disease and heart disease.
Yale Launches New Policy Lab to Elevate Mental Health and Disrupt Poverty
Elevate is a new policy laboratory stemming from the successful work of the Mental health Outreach for MotherS (MOMS) Partnership and joining forces with Women’s Health Research at Yale (WHRY) to apply science to the creation and spread of evidence-based interventions for socially and economically disadvantaged families in partnership with government agencies.
Biomarker Reveals PTSD Sufferers at Risk of Suicide
The risk of suicide among individuals with post-traumatic stress disorder (PTSD) is much higher than the general population, but identifying those individuals at greatest risk has been difficult. However, a team at Yale has discovered a biological marker linked to individuals with PTSD who are most likely to think about suicide, the researchers report May 13 in the journal Proceedings of the National Academy of Sciences.
Yonkers, Forray Co-PIs on New Grant to Study Medication Delivery for Pregnant Women with Opioid Use Disorders
Kimberly Yonkers, MD, Professor of Psychiatry, of Epidemiology (Chronic Diseases) and of Obstetrics, Gynecology, and Reproductive Services, and Ariadna Forray, MD, Associate Professor of Psychiatry, are co-principal investigators on a new $5.5 million grant to study models to improve delivery of office-based medication treatment for pregnant women with opioid use disorder in prenatal clinics.
Behavioral disorders in kids with autism linked to reduced brain connectivity
More than a quarter of children with autism spectrum disorder are also diagnosed with disruptive behavior disorders. For the first time, Yale researchers have identified a possible biological cause: a key mechanism that regulates emotion functions differently in the brains of the children who exhibit disruptive behavior.
Don't Jump for Joy over New FDA-approved Postpartum Depression Medicine Yet
Kimberly Yonkers, MD, Professor of Psychiatry, of Epidemiology (Chronic Diseases) and of Obstetrics, Gynecology, and Reproductive Sciences cautions new mothers who may consider taking the new FDA-approved medication for postpartum depression in an opinion piece published in USA Today.
FDA Approves First Postpartum Depression Drug, but Access Is an Issue
Kimberly Yonkers, MD, Professor of Psychiatry, of Epidemiology (Chronic Diseases) and of Obstetrics, Gynecology, and Reproductive Sciences, speaks to NPR about the U.S. Food and Drug Administration's approval of Zulresso, the first drug specifically for postpartum depression.